Dyadic Logo Current.jpg
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
14. Dezember 2022 08:30 ET | Dyadic International, Inc.
“Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge” Study supports: Dyadic’s...
Prof Felicity Burt
The new Omicron variant: What we know and don’t know
01. Dezember 2021 05:56 ET | University of the Free state
Bloemfontein, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Even though not much is yet known about the new COVID-19 variant, Omicron, the presence of a high number of mutations – more than 30 – in the spike...